Skip to main content
Log in

Acid Suppression in Neonates: Friend or Foe?

  • Perspective
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Medications that reduce gastric acid secretion are commonly prescribed for treating gastroesophageal reflux disease. However, several studies have shown that these medications are not very effective, and are associated with adverse effects. This article discusses the physiology of gastric acid secretion, clinical indications and pharmacology of acid suppressing medications, and possible adverse effects of these medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eichenwald EC; Committee on Fetus and Newborn. Diagnosis and management of gastroesophageal reflux in preterm infants. Pediatrics. 2018;142: pii:e20181061.

    Article  Google Scholar 

  2. Winter H, Kum-Nji P, Mahomedy SH, Kierkus J, Hinz M, Li H, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1–11 months old with symptomatic GERD. J Pediatr Gastroenterol Nutr. 2010;50:609–18.

    Article  CAS  PubMed  Google Scholar 

  3. Tighe M, Afzal NA, Bevan A, Hayen A, Munro A, Beattie RM. Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database Syst Rev. 2014;11:CD008550.

    Google Scholar 

  4. Peter CS, Wiechers C, Bohnhorst B, Silny J, Poets CF. Influence of nasogastric tubes on gastroesophageal reflux in preterm infants: A multiple intraluminal impedance study. J Pediatr. 2002;141:277–9.

    Article  PubMed  Google Scholar 

  5. Richardson CT, Walsh JH, Cooper KA, Feldman M, Fordtran JS. Studies on the role of cephalic-vagal stimulation in the acid secretory response to eating in normal human subjects. J Clin Invest. 1977;60:435–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Frakaloss G, Burke G, Sanders MR. Impact of gastroesophageal reflux on growth and hospital stay in premature infants. J Pediatr Gastroenterol Nutr. 1998;26:146–50.

    Article  CAS  PubMed  Google Scholar 

  7. El-Mahdy MA, Mansoor FA, Jadcherla SR. Pharmacological management of gastroesophageal reflux disease in infants: current opinions. Curr Opin Pharmacol. 2017;37:112–7.

    Article  CAS  PubMed  Google Scholar 

  8. Ghaem M, Armstrong KL, Trocki O, Cleghorn GJ, Patrick MK, Shepherd RW. The sleep patterns of infants and young children with gastro-oesophageal reflux. J Paediatr Child Health. 1998;34:160–3.

    Article  CAS  PubMed  Google Scholar 

  9. Mercado-Deane MG, Burton EM, Harlow SA, Glover AS, Deane DA, Guill MF, et al. Swallowing dysfunction in infants less than 1 year of age. Pediatr Radiol. 2001;31:423–8.

    Article  CAS  PubMed  Google Scholar 

  10. Da Dalt L, Mazzoleni S, Montini G, Donzelli F, Zacchello F. Diagnostic accuracy of pH monitoring in gastro-oesophageal reflux. Arch Dis Child. 1989;64:1421–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:516–54.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 2001;32:S1–31.

    Article  Google Scholar 

  13. Tsou VM, Young RM, Hart MH, Vanderhoof JA. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics. 1991;87:148–51.

    CAS  PubMed  Google Scholar 

  14. Tsou VM, Bishop PR. Gastroesophageal reflux in children. Otolaryngol Clin North Am. 1998;31:419–34.

    Article  CAS  PubMed  Google Scholar 

  15. Mihatsch WA, Hogel J, Pohlandt F. Hydrolysed protein accelerates the gastrointestinal transport of formula in preterm infants. Acta Paediatr. 2001;90:196–8.

    Article  CAS  PubMed  Google Scholar 

  16. Chicella MF, Batres LA, Heesters MS, Dice JE. Prokinetic drug therapy in children: a review of current options. Ann Pharmacother. 2005;39:706–11.

    Article  CAS  PubMed  Google Scholar 

  17. Ballengee CR, Davalian F, Conaway MR, Sauer CG, Kaufman DA. Erythromycin and Reflux Events in Premature Neonates: A Randomized Clinical Trial. J Pediatr Gastroenterol Nutr. 2018;67:720–5.

    Article  CAS  PubMed  Google Scholar 

  18. Orenstein SR, Shalaby TM, Devandry SN, Liacouras CA, Czinn SJ, Dice JE, et al. Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial. Aliment Pharmacol Ther. 2003;17:1097–107.

    Article  CAS  PubMed  Google Scholar 

  19. Cucchiara S, Minella R, Iervolino C, Franco MT, Campanozzi A, Franceschi M, et al. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Arch Dis Child. 1993;69:655–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143:219–23.

    Article  CAS  PubMed  Google Scholar 

  21. Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr. 2007;44:41–4.

    Article  CAS  PubMed  Google Scholar 

  22. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45:421–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Funding: None; Competing interests: None stated.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abhay Lodha.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murthy, P., Dosani, A. & Lodha, A. Acid Suppression in Neonates: Friend or Foe?. Indian Pediatr 56, 541–546 (2019). https://doi.org/10.1007/s13312-019-1549-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-019-1549-8

Keywords

Navigation